345 related articles for article (PubMed ID: 34067931)
1. Understanding the Role of Perilipin 5 in Non-Alcoholic Fatty Liver Disease and Its Role in Hepatocellular Carcinoma: A Review of Novel Insights.
Mass Sanchez PB; Krizanac M; Weiskirchen R; Asimakopoulos A
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067931
[TBL] [Abstract][Full Text] [Related]
2. Lipid-Independent Regulation of PLIN5 via IL-6 through the JAK/STAT3 Axis in Hep3B Cells.
Krizanac M; Mass Sanchez PB; Schröder SK; Weiskirchen R; Asimakopoulos A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108378
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Perilipin 5 Protects Against Hepatic Injury in Nonalcoholic Fatty Liver Disease via Missing Inflammasome Activation.
Asimakopoulou A; Engel KM; Gassler N; Bracht T; Sitek B; Buhl EM; Kalampoka S; Pinoé-Schmidt M; van Helden J; Schiller J; Weiskirchen R
Cells; 2020 May; 9(6):. PubMed ID: 32481590
[TBL] [Abstract][Full Text] [Related]
4. Perilipin 5 Protects against Cellular Oxidative Stress by Enhancing Mitochondrial Function in HepG2 Cells.
Tan Y; Jin Y; Wang Q; Huang J; Wu X; Ren Z
Cells; 2019 Oct; 8(10):. PubMed ID: 31614673
[No Abstract] [Full Text] [Related]
5. Deranged hepatocyte intracellular Ca
Ali ES; Rychkov GY; Barritt GJ
Cell Calcium; 2019 Sep; 82():102057. PubMed ID: 31401389
[TBL] [Abstract][Full Text] [Related]
6. A new perspective on NAFLD: Focusing on lipid droplets.
Scorletti E; Carr RM
J Hepatol; 2022 Apr; 76(4):934-945. PubMed ID: 34793866
[TBL] [Abstract][Full Text] [Related]
7. A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma.
Krizanac M; Mass Sanchez PB; Weiskirchen R; Asimakopoulos A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799862
[TBL] [Abstract][Full Text] [Related]
8. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
[TBL] [Abstract][Full Text] [Related]
9. Perilipin 5 alleviates HCV NS5A-induced lipotoxic injuries in liver.
Zhang J; Gao X; Yuan Y; Sun C; Zhao Y; Xiao L; Yang Y; Gu Y; Yang R; Hu P; Zhang L; Wang C; Ye J
Lipids Health Dis; 2019 Apr; 18(1):87. PubMed ID: 30954078
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.
Nakamura N; Hatano E; Iguchi K; Sato M; Kawaguchi H; Ohtsu I; Sakurai T; Aizawa N; Iijima H; Nishiguchi S; Tomono T; Okuda Y; Wada S; Seo S; Taura K; Uemoto S; Ikegawa M
BMC Cancer; 2019 Jun; 19(1):621. PubMed ID: 31238892
[TBL] [Abstract][Full Text] [Related]
11. Plin5, a New Target in Diabetic Cardiomyopathy.
Cui X; Wang J; Zhang Y; Wei J; Wang Y
Oxid Med Cell Longev; 2022; 2022():2122856. PubMed ID: 35509833
[TBL] [Abstract][Full Text] [Related]
12. SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism.
M Onorato A; Fiore E; Bayo J; Casali C; Fernandez-Tomé M; Rodríguez M; Domínguez L; Argemi J; Hidalgo F; Favre C; García M; Atorrasagasti C; Mazzolini GD
Liver Int; 2021 Jul; 41(7):1677-1693. PubMed ID: 33641248
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD).
Flessa CM; Kyrou I; Nasiri-Ansari N; Kaltsas G; Kassi E; Randeva HS
J Cell Biochem; 2022 Oct; 123(10):1585-1606. PubMed ID: 35490371
[TBL] [Abstract][Full Text] [Related]
14. Role of Plin5 Deficiency in Progression of Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice.
Ma Y; Yin X; Qin Z; Ke X; Mi Y; Zheng P; Tang Y
J Comp Pathol; 2021 Nov; 189():88-97. PubMed ID: 34886991
[TBL] [Abstract][Full Text] [Related]
15. Autophagy, NAFLD and NAFLD-Related HCC.
Wu WKK; Zhang L; Chan MTV
Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
[TBL] [Abstract][Full Text] [Related]
16. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
17. Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth.
Dashti Z; Yousefi Z; Kiani P; Taghizadeh M; Maleki MH; Borji M; Vakili O; Shafiee SM
Metabolism; 2024 May; 154():155811. PubMed ID: 38309690
[TBL] [Abstract][Full Text] [Related]
18. Disruption of Plin5 degradation by CMA causes lipid homeostasis imbalance in NAFLD.
Ma SY; Sun KS; Zhang M; Zhou X; Zheng XH; Tian SY; Liu YS; Chen L; Gao X; Ye J; Zhou XM; Wang JB; Han Y
Liver Int; 2020 Oct; 40(10):2427-2438. PubMed ID: 32339374
[TBL] [Abstract][Full Text] [Related]
19. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.
Xu W; Zhang X; Wu JL; Fu L; Liu K; Liu D; Chen GG; Lai PB; Wong N; Yu J
J Hepatol; 2017 Aug; 67(2):310-320. PubMed ID: 28347804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
